Skip to main navigation
Tenaya Therapeutics
  • Careers at Tenaya
  • Contact Us
  • Leadership
  • Our Science
    • Platforms
    • Capabilities
    • Collaborations
    • Publications & Presentations
  • Our Programs
    • Pipeline
    • Programs
  • Patients & Families
    • Overview
    • Tenaya Approach
    • Advocacy Partners
    • Studies
    • Our Inspiration
    • Resources
  • Investors
    • News & Events
      • Press Releases
      • In the News
      • Events & Presentations
    • Corporate Governance
      • Governance Overview
      • Board of Directors
      • Management
      • Committee Composition
    • Financial Information
      • SEC Filings
      • Quarterly Results
    • Stock Information
      • Stock Quote & Chart
    • IR Resources
      • Investor FAQs
      • Contact IR
      • Email Alerts

Investor Portal

Nov 29, 2021
Cell & Gene Collaborative: The Ties That Bind: Engineering A CGT Manufacturing-Centric Culture
Nov 05, 2021
Barron's: Gene Therapy Is a Huge Opportunity. It Pays to be Patient.
Oct 18, 2021
The Science Advisory Board: Cardiovascular cell, gene therapy leaders discuss nascent field
Sep 20, 2021
Life Science Connect: Living Happily Ever After With Your Cell Therapy Facility: Where Do You Start?
Sep 17, 2021
Future Medicine: Living with hypertrophic cardiomyopathy: the patient’s perspective
Dec 17, 2020
STAT: Talent, culture, and ethics are all necessary ingredients in the biotech recipe for success
Dec 10, 2020
Genetic Engineering and Biotechnology News: Navigating the Complexities of AAV Scale-Up and Manufacturing
Jun 07, 2020
Cell and Gene Therapy Insights: The heart of market access - opportunities and challenges for cell and gene therapy development for orphan and prevalent cardiovascular diseases
Mar 01, 2018
Science Daily: Unlocking a cell’s potential to regenerate the heart

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Current page 2
RSS Feeds
Email Alerts
Contact IR
Print

Privacy Policy | Terms of Use    © 2023 Tenaya Therapeutics. All rights reserved.